GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

Accueil・Liste d'Actions・BioArctic AB

B
BioArctic AB

Fermé

290 -7.29

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

272.2

Max

312.8

Chiffres clés
By Trading Economics
Revenu	-979M 97M
Ventes	-897M 392M
P/E Moyenne du Secteur	25.665 35.733
BPA	1.09
Marge bénéficiaire	24.623
Employés	119
EBITDA	1.1B 1.1B

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	6.6B 27B
Ouverture précédente	297.29
Clôture précédente	290

BioArctic AB Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

4 sept. 2025, 20:46 UTC

Résultats

Costco Wholesale Posts Sales Gains in August

4 sept. 2025, 20:42 UTC

Résultats

Broadcom Swings to 3Q Profit, Beats on Sales Outlook

4 sept. 2025, 23:02 UTC

Market Talk

Sky Network TV's Latest Deal Looks Strategically Smart -- Market Talk

4 sept. 2025, 21:46 UTC

Actions en Tendance

Lululemon, Broadcom, Docusign: Stocks to Watch Afterhours -- WSJ

4 sept. 2025, 21:23 UTC

Résultats

Broadcom Stock Rises on New AI Chip Customer Order After Earnings Beat -- Barrons.com

4 sept. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4 sept. 2025, 20:37 UTC

Résultats

Broadcom Posts Earnings Beat. The Stock Is Wavering. -- Barrons.com

4 sept. 2025, 20:32 UTC

Acquisitions, Fusions, Rachats

Cadence Design Systems: 70% of Consideration to Be Paid in Cash and 30% to Be Paid Through Issuance of Stk to Hexagon >CDNS

4 sept. 2025, 20:31 UTC

Acquisitions, Fusions, Rachats

GE Aerospace Moves Toward Hybrid Electric Engines. The Stock Is Up. -- Barrons.com

4 sept. 2025, 20:31 UTC

Acquisitions, Fusions, Rachats

Cadence Design Systems Will Pay About EUR2.7 B for the Business >CDNS

4 sept. 2025, 20:31 UTC

Acquisitions, Fusions, Rachats

Cadence Design Systems: Acquisition Will Complement System Analysis Portfolio for Automotive, Aerospace, Industrial and Robotics >CDNS

4 sept. 2025, 20:31 UTC

Acquisitions, Fusions, Rachats

Cadence Design Systems to Acquire Design & Engineering Business of Hexagon AB >CDNS

4 sept. 2025, 20:25 UTC

Résultats

Broadcom Beats Earnings. The Stock Wavers. -- Barrons.com

4 sept. 2025, 20:17 UTC

Résultats

Broadcom 3Q Infrastructure Software Net Revenue $6.79B >AVGO

4 sept. 2025, 20:17 UTC

Résultats

Broadcom 3Q Semiconductor Solutions Net Revenue $9.17B >AVGO

4 sept. 2025, 20:15 UTC

Résultats

Broadcom 3Q EPS 85c >AVGO

4 sept. 2025, 20:15 UTC

Résultats

Broadcom 3Q Cont Ops EPS 85c >AVGO

4 sept. 2025, 20:15 UTC

Résultats

Broadcom 3Q Adj EPS $1.69 >AVGO

4 sept. 2025, 20:15 UTC

Résultats

Broadcom 3Q Net $4.14B >AVGO

4 sept. 2025, 20:15 UTC

Résultats

Broadcom 3Q Rev $15.95B >AVGO

4 sept. 2025, 20:15 UTC

Résultats

Broadcom Sees 4Q Rev $17.4B >AVGO

4 sept. 2025, 19:33 UTC

Acquisitions, Fusions, Rachats

Private-Equity Firm Pays $2.7 Billion to Buy Back Wealth Firms It Sold Last Year -- Barrons.com

4 sept. 2025, 19:33 UTC

Market Talk

Oil Futures Post Back-to-Back Losses -- Market Talk

4 sept. 2025, 19:14 UTC

Market Talk

U.S. Natural Gas Edges Up As Storage Meets Expectations -- Market Talk

4 sept. 2025, 18:48 UTC

Résultats

These Stocks Are Moving the Most Today: Figma, T. Rowe Price, Credo, Salesforce, American Eagle, HPE, Ciena, and More -- Barrons.com

4 sept. 2025, 17:54 UTC

Acquisitions, Fusions, Rachats

T. Rowe Stock Jumps After Goldman Agrees to Invest $1 Billion, Partner on Private Funds -- WSJ

4 sept. 2025, 17:54 UTC

Acquisitions, Fusions, Rachats

Fiserv Didn't Disclose Financial Terms of CardFree Transaction >FI

4 sept. 2025, 17:54 UTC

Acquisitions, Fusions, Rachats

Fiserv: CardFree an All-In-One Platform Providing Merchants With Customized Order, Pay, and Loyalty Solutions >FI

4 sept. 2025, 17:54 UTC

Acquisitions, Fusions, Rachats

Fiserv Has Acquired CardFree >FI

4 sept. 2025, 17:15 UTC

Market Talk

Résultats

Global Equities Roundup: Market Talk

Comparaison

Variation de prix

BioArctic AB prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.